Daily Progress: Gilead Sciences, Inc (GILD) Gain 1.27, Closing at 89.76

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Gilead Sciences, Inc (NASDAQ: GILD) closed at $89.76 up 1.27% from its previous closing price of $88.63. In other words, the price has increased by $1.27 from its previous closing price. On the day, 4.06 million shares were traded. GILD stock price reached its highest trading level at $89.94 during the session, while it also had its lowest trading level at $88.07.

Ratios:

For a deeper understanding of Gilead Sciences, Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.70 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.86. For the most recent quarter (mrq), Quick Ratio is recorded 1.10 and its Current Ratio is at 1.26. In the meantime, Its Debt-to-Equity ratio is 1.26 whereas as Long-Term Debt/Eq ratio is at 1.16.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on November 15, 2024, initiated with a Outperform rating and assigned the stock a target price of $110.

On November 14, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $125.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 06 ’24 when Mercier Johanna sold 5,000 shares for $91.28 per share. The transaction valued at 456,400 led to the insider holds 73,127 shares of the business.

Parsey Merdad sold 25,590 shares of GILD for $2,341,485 on Nov 06 ’24. The Chief Medical Officer now owns 99,599 shares after completing the transaction at $91.50 per share. On Nov 06 ’24, another insider, MERDAD V PARSEY, who serves as the Officer of the company, bought 25,590 shares for $91.50 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GILD now has a Market Capitalization of 111865192448 and an Enterprise Value of 126924546048. As of this moment, Gilead’s Price-to-Earnings (P/E) ratio for their current fiscal year is 1011.95, and their Forward P/E ratio for the next fiscal year is 11.98. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 126.49. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.96 while its Price-to-Book (P/B) ratio in mrq is 6.05. Its current Enterprise Value per Revenue stands at 4.485 whereas that against EBITDA is 9.099.

Stock Price History:

Over the past 52 weeks, GILD has reached a high of $98.90, while it has fallen to a 52-week low of $62.07. The 50-Day Moving Average of the stock is 2.84%, while the 200-Day Moving Average is calculated to be 19.54%.

Shares Statistics:

For the past three months, GILD has traded an average of 6.69M shares per day and 9104180 over the past ten days. A total of 1.25B shares are outstanding, with a floating share count of 1.25B. Insiders hold about 0.10% of the company’s shares, while institutions hold 85.36% stake in the company. Shares short for GILD as of 1730332800 were 17744662 with a Short Ratio of 2.65, compared to 1727654400 on 17735062. Therefore, it implies a Short% of Shares Outstanding of 17744662 and a Short% of Float of 1.43.

Dividends & Splits

According to the company, the forward annual dividend rate for GILD is 3.06, from 3.06 in the trailing year. Against a Trailing Annual Dividend Yield of 0.034525555The stock’s 5-year Average Dividend Yield is 4.02.

Most Popular